Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?

SUMMARY: Serious adverse events of infections that occurred in subjects receiving denosumab or placebo in the Fracture Reduction Evaluation of Denosumab in Osteoporosis every 6 Months (FREEDOM) study were examined in detail. Serious adverse events of infections in denosumab subjects had heterogeneou...

Descripción completa

Detalles Bibliográficos
Autores principales: Watts, N. B., Roux, C., Modlin, J. F., Brown, J. P., Daniels, A., Jackson, S., Smith, S., Zack, D. J., Zhou, L., Grauer, A., Ferrari, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249159/
https://www.ncbi.nlm.nih.gov/pubmed/21892677
http://dx.doi.org/10.1007/s00198-011-1755-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249159/
https://www.ncbi.nlm.nih.gov/pubmed/21892677
http://dx.doi.org/10.1007/s00198-011-1755-2

Ejemplares similares